Deciphering the combinatorial landscape of immunity.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
23 11 2020
Historique:
received: 15 08 2020
accepted: 05 11 2020
pubmed: 24 11 2020
medline: 19 3 2021
entrez: 23 11 2020
Statut: epublish

Résumé

From cellular activation to drug combinations, immunological responses are shaped by the action of multiple stimuli. Synergistic and antagonistic interactions between stimuli play major roles in shaping immune processes. To understand combinatorial regulation, we present the immune Synergistic/Antagonistic Interaction Learner (iSAIL). iSAIL includes a machine learning classifier to map and interpret interactions, a curated compendium of immunological combination treatment datasets, and their global integration into a landscape of ~30,000 interactions. The landscape is mined to reveal combinatorial control of interleukins, checkpoints, and other immune modulators. The resource helps elucidate the modulation of a stimulus by interactions with other cofactors, showing that TNF has strikingly different effects depending on co-stimulators. We discover new functional synergies between TNF and IFNβ controlling dendritic cell-T cell crosstalk. Analysis of laboratory or public combination treatment studies with this user-friendly web-based resource will help resolve the complex role of interaction effects on immune processes.

Identifiants

pubmed: 33225996
doi: 10.7554/eLife.62148
pii: 62148
pmc: PMC7748411
doi:
pii:

Substances chimiques

Immune Checkpoint Inhibitors 0
Immunologic Factors 0
Interleukins 0
Tumor Necrosis Factor-alpha 0
Interferon-beta 77238-31-4

Banques de données

GEO
['GSE134209']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Research Council
ID : IT-DC 281987
Pays : International
Organisme : Agence Nationale de la Recherche
ID : ANR-11-LABX-0043 CIC IGR-Curie 1428
Pays : International
Organisme : NIAID NIH HHS
ID : U19 AI117873
Pays : United States
Organisme : European Research Council
ID : 680890
Pays : International
Organisme : Defense Advanced Research Projects Agency
ID : N6600119C4022
Pays : International

Informations de copyright

© 2020, Cappuccio et al.

Déclaration de conflit d'intérêts

AC, SJ, BH, SS, VS, EZ No competing interests declared

Références

Int Rev Immunol. 2018 Jan 2;37(1):20-36
pubmed: 29028369
Blood. 2012 Mar 29;119(13):3050-9
pubmed: 22327222
Curr Protoc Bioinformatics. 2016 Jun 20;54:1.30.1-1.30.33
pubmed: 27322403
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Bioinformatics. 2007 Jul 15;23(14):1846-7
pubmed: 17496320
J Immunol. 2007 Mar 15;178(6):3865-73
pubmed: 17339486
Front Immunol. 2015 Feb 03;6:34
pubmed: 25691885
Nat Med. 2017 Oct 6;23(10):1113
pubmed: 28985211
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Clin Immunol. 2002 Mar;102(3):302-9
pubmed: 11890717
Int J Mol Sci. 2017 Oct 23;18(10):
pubmed: 29065550
Nat Cell Biol. 2004 Feb;6(2):97-105
pubmed: 14743216
J Immunol. 2012 Feb 15;188(4):1789-98
pubmed: 22250091
Nat Rev Immunol. 2012 Jan 06;12(2):125-35
pubmed: 22222875
Nat Commun. 2015 Apr 21;6:6847
pubmed: 25896517
Nature. 2017 Dec;552(7685):S67-S69
pubmed: 32094671
Science. 2013 Mar 22;339(6126):1448-53
pubmed: 23449998
Annu Rev Immunol. 2009;27:591-619
pubmed: 19132916
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Front Immunol. 2014 Feb 26;5:73
pubmed: 24616721
PLoS One. 2012;7(1):e30596
pubmed: 22299046
Nature. 2014 May 8;509(7499):235-9
pubmed: 24739962
J Cheminform. 2015 Feb 26;7:7
pubmed: 25741385
Nat Commun. 2019 Jun 17;10(1):2674
pubmed: 31209238
Bioinformatics. 2018 May 1;34(9):1538-1546
pubmed: 29253077
Pac Symp Biocomput. 2015;:68-79
pubmed: 25592569
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
Nat Commun. 2017 Dec 5;8(1):1931
pubmed: 29203926
Nat Rev Rheumatol. 2016 Jan;12(1):49-62
pubmed: 26656660
J Biol Chem. 2007 Jul 13;282(28):20047-51
pubmed: 17502369
Immunol Res. 2014 May;58(2-3):234-9
pubmed: 24791905
Nat Biotechnol. 2004 Jun;22(6):656-8; author reply 658
pubmed: 15175677
Pharmacol Rev. 2006 Sep;58(3):621-81
pubmed: 16968952
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Cell. 2001 Feb 23;104(4):487-501
pubmed: 11239407

Auteurs

Antonio Cappuccio (A)

Institut Curie, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, PSL Research University, Inserm, U932, Paris, France.
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States.

Shane T Jensen (ST)

Department of Statistics, Wharton School, University of Pennsylvania, Philadelphia, United States.

Boris M Hartmann (BM)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States.

Stuart C Sealfon (SC)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States.

Vassili Soumelis (V)

Institut Curie, Integrative Biology of Human Dendritic Cells and T Cells Laboratory, PSL Research University, Inserm, U932, Paris, France.
Laboratoire d'immunologie, biologie et histocompatibilité, AP-HP, Hôpital Saint-Louis, Paris, France.

Elena Zaslavsky (E)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH